AI for New Medical
Experience
Ainex develops AI technologies that enhance diagnostic
accuracy for clinicians and help save patients’ lives.
Defining the Future Standard of
Endoscopy in the Age of AI
Ainex, a leader in AI-driven healthcare innovation,
delivers advanced solutions that are validated in real clinical environments
to benefit both patients and medical professionals.
With ENAD—our AI-powered diagnostic support software for gastrointestinal endoscopy
—we are redefining the paradigm of endoscopic diagnosis and establishing ourselves
at the forefront of the global endoscopy AI market.
Ainex delivers clinically validated AI solutions to redefine endoscopic diagnosis and lead global healthcare innovation.
Our Mission
We deliver a new standard of medical experience through AI technology,contributing to the prevention and early detection of gastrointestinal cancers with our innovative AI-powered diagnostic support solutions for upper and lower GI endoscopy.
Our Vision
Ainex aspires to enable healthier, happier lives for everyone.By setting a new benchmark in medical AI solutions, we aim to become a global partner that helps shape a healthier future for people around the world.
Milestone of Innovation
Ainex is leading the advancement of gastrointestinal endoscopy by elevating diagnostic quality through innovative AI technology.
Learn more about who we are and discover how we are shaping the future of endoscopic diagnostics.
Elevating endoscopy through AI innovation. Discover how Ainex is shaping the future of diagnostics.
Designated as an Innovative Product (2nd Round, 2026) by the Public Procurement Service (PPS) – ENAD CADx
Vietnam (MOH) approval (AI for upper GI endoscopy diagnosis, Class B)
MFDS approval for medical device software (AI for upper GI endoscopy diagnosis, Class 3)
Selected as a “Next-Generation World-Class Product 2025” by KOTRA
Malaysia (MDA) approval (AI for upper & lower GI endoscopy diagnosis, Class B)
Certified as a “Hi-Seoul Company 2025” by the Seoul Business Agency
Passed the Integrated Review for Innovative Medical Devices (AI-based colorectal cancer detection & diagnostic support software)
Vietnam (MOH) approval (AI for upper & lower GI endoscopy detection and colonoscopy diagnosis, Class B)
Indonesia (MOH) approval (AI for upper & lower GI endoscopy detection, Class C)
MFDS approval for medical device software (AI for lower GI endoscopy diagnosis, Class 3)
Colombia (INVIMA) approval (AI for upper & lower GI endoscopy detection, Class IIa)
Selected for the 2025 Scale-up Startup Package by the Ministry of SMEs and Startups (MSS)
Singapore (HSA) approval (AI for upper & lower GI endoscopy detection, Class B)
Malaysia (MDA) approval (AI for upper & lower GI endoscopy detection, Class B)
Designated as an Innovative Medical Device for AI-based colorectal cancer detection & diagnostic support software
Thailand (TFDA) approval (AI for upper & lower GI endoscopy detection, Class II)
Designated as an Innovative Product (2nd Round, 2024) by the Public Procurement Service (PPS) - ENAD
Selected as a “Baby Unicorn” company by the Ministry of SMEs and Startups (MSS)
Commencement of overseas exports (Vietnam)
MFDS certification for medical device software (AI for upper & lower GI endoscopy detection, Class 2)
Winner of the CES 2023 Digital Health Innovation Award
Winner of the Gastroenterology Track Award at MICCAI 2022
Clinical validation studies conducted at medical institutions
Research collaboration with the Division of Gastroenterology, Seoul National University Hospital (SNUH) on gastric and esophageal AI
Company founded
Commercially Available in 7 Countries
and Expanding Rapidly
Trusted by hospitals across Asia and rapidly growing across Latin America, Europe, and beyond.
Awards & Recognition
Proven safety.
Trusted expertise.
Our Partnership
Ainex is advancing the development and enhancement of its AI solutions through close collaboration and
strategic partnerships with leading medical institutions in Korea and around the world.
Join Our Team
Join us in leading the endoscopy diagnosis revolution!
Be part of a team transforming GI healthcare with cutting-edge technology and open innovation.
